Estrogen and cardiovascular function after menopause

Department of Medicine, University of New Mexico Health Sciences, Albuquerque 87131, USA.

Nonrandomized trials of postmenopausal estrogen replacement have shown a benefit in the prevention of coronary artery disease. Less clear are the specific mechanisms by which this occurs. Estrogen has beneficial effects on the lipid profile, with significant elevations in high density lipoprotein cholesterol and reductions in low density lipoprotein cholesterol reported. Also, antioxidant properties have been ascribed to estrogen. In addition, estrogen has been shown to prevent paradoxic vasoconstriction in atherosclerotic coronary arteries after acetylcholine and may have calcium channel-blocking and alpha2-inhibiting properties. Other proposed mechanisms of cardiovascular protection include reductions in serum fibrinogen and increases in prostacyclin biosynthesis. There is some evidence that cardiovascular biomechanics may be mildly depressed after menopause and that estrogen may normalize these changes by increasing ventricular contractility and, possibly, relaxation. Far less is known about the cardiovascular effects of progesterone, but overall it does not appear that the less androgenic progestins substantially modify the effects of estrogen. Because more women > 50 years old die of cardiovascular disease than any other cause, further clinical investigations of the risks and benefits of estrogen replacement and combined estrogen and progesterone therapy are clearly needed.

This article has been cited by other articles:

				L. K. McClanahan, G. E. Aiken, and C. T. Dougherty Case Study: Influence of Rough Hair Coats and Steroid Implants on the Performance and Physiology of Steers Grazing Endophyte-Infected Tall Fescue in the Summer Professional Animal Scientist, June 1, 2008; 24(3): 269 - 276. [Abstract] [PDF]

				I. Mercier, S. Mader, and A. Calderone Tamoxifen and ICI 182,780 negatively influenced cardiac cell growth via an estrogen receptor-independent mechanism Cardiovasc Res, October 1, 2003; 59(4): 883 - 892. [Abstract] [Full Text] [PDF]

				S. Adamopoulos, D. Leftheriotis, E. Sbarouni, G. Karavolias, and D. T. Kremastinos Acute haemodynamic effects of oestrogen administration in male patients with chronic heart failure Eur J Heart Fail, December 1, 2002; 4(6): 719 - 726. [Abstract] [Full Text] [PDF]

				A. Wakatsuki, Y. Ogawa, T. Saibara, Y. Okatani, and T. Fukaya Size and Oxidative Susceptibility of Low-Density Lipoprotein Particles in Breast Cancer Patients with Tamoxifen-Induced Fatty Liver J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3676 - 3681. [Abstract] [Full Text] [PDF]

				M Sitges, M Heras, E Roig, M Duran, M Masotti, M.J Zurbano, M Roque, and G Sanz Acute and mid-term combined hormone replacement therapy improves endothelial function in post-menopausal women with angina and angiographically normal coronary arteries Eur. Heart J., November 2, 2001; 22(22): 2116 - 2124. [Abstract] [PDF]

				A. Wakatsuki, N. Ikenoue, Y. Okatani, and T. Fukaya Estrogen-induced small low density lipoprotein particles may be atherogenic in postmenopausal women J. Am. Coll. Cardiol., February 1, 2001; 37(2): 425 - 430. [Abstract] [Full Text] [PDF]

				K. J. Mather, E. G. Norman, J. C. Prior, and T. G. Elliott Preserved Forearm Endothelial Responses with Acute Exposure to Progesterone: A Randomized Cross-Over Trial of 17-{beta} Estradiol, Progesterone, and 17-{beta} Estradiol with Progesterone in Healthy Menopausal Women J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4644 - 4649. [Abstract] [Full Text]

				E Sbarouni, C Kroupis, Z.S Kyriakides, K Koniavitou, and D.T Kremastinos Cell adhesion molecules in relation to simvastatin and hormone replacement therapy in coronary artery disease Eur. Heart J., June 2, 2000; 21(12): 975 - 980. [Abstract] [PDF]

				A.S Fak, M Erenus, H Tezcan, O Caymaz, P AtagunduZ, S Oktay, and A Oktay Effects of simvastatin only or in combination with continuous combined hormone replacement therapy on serum lipid levels in hypercholesterolaemic post-menopausal women Eur. Heart J., February 1, 2000; 21(3): 190 - 197. [Abstract] [PDF]

				A. M. Persky, P. S. Green, L. Stubley, C. O. Howell, L. Zaulyanov, G. A. Brazeau, and J. W. Simpkins Protective Effect of Estrogens Against Oxidative Damage to Heart and Skeletal Muscle In Vivo and In Vitro Experimental Biology and Medicine, January 1, 2000; 223(1): 59 - 66. [Abstract] [Full Text]

				G Vacca, A Battaglia, E Grossini, D A S G Mary, C Molinari, and N Surico The effect of 17{beta}-oestradiol on regional blood flow in anaesthetized pigs J. Physiol., February 1, 1999; 514(3): 875 - 884. [Abstract] [Full Text] [PDF]

				G. Schillaci, P. Verdecchia, C. Borgioni, A. Ciucci, and C. Porcellati Early Cardiac Changes After Menopause Hypertension, October 1, 1998; 32(4): 764 - 769. [Abstract] [Full Text] [PDF]

				S. Hulley, D. Grady, T. Bush, C. Furberg, D. Herrington, B. Riggs, E. Vittinghoff, and for the Heart and Estrogen/progestin Replacement S Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women JAMA, August 19, 1998; 280(7): 605 - 613. [Abstract] [Full Text] [PDF]

				R. A. Vogel and M. C. Corretti Estrogens, Progestins, and Heart Disease : Can Endothelial Function Divine the Benefit? Circulation, April 7, 1998; 97(13): 1223 - 1226. [Full Text] [PDF]

				G. Davey Smith, S. Ebrahim, J. R. Crouse III, R. P. Byington, H. M. Hoen, and C. D. Furberg Lowering of Cholesterol Levels and the Risk of Stroke Arch Intern Med, January 12, 1998; 158(1): 98 - 99. [Full Text] [PDF]

				D. C. Schwenke Gender Differences in Intima-Media Permeability to Low-Density Lipoprotein at Atherosclerosis-Prone Aortic Sites in Rabbits : Lack of Effect of 17ß-Estradiol Arterioscler Thromb Vasc Biol, October 1, 1997; 17(10): 2150 - 2157. [Abstract] [Full Text]

				B. D. Johnson, W. Zheng, K. S. Korach, T. Scheuer, W. A. Catterall, and G. M. Rubanyi Increased Expression of the Cardiac L-type Calcium Channel in Estrogen Receptor-deficient Mice J. Gen. Physiol., August 1, 1997; 110(2): 135 - 140. [Abstract] [Full Text] [PDF]

				S. Sunayama, H. Daida, H. Mokuno, H. Miyano, H. Yokoi, Y. J. Lee, H. Sakurai, and H. Yamaguchi Lack of Increased Coronary Atherosclerotic Risk Due to Elevated Lipoprotein(a) in Women >=55 Years of Age Circulation, September 15, 1996; 94(6): 1263 - 1268. [Abstract] [Full Text]